Evofem Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evofem Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $219K, a 18.3% decline year-over-year.
  • Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $960K, a 48.1% decline year-over-year.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.19M, a 64.1% decline from 2022.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.31M, a 62.8% decline from 2021.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.9M, a 29.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $960K $219K -$49K -18.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.01M $237K -$180K -43.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.19M $246K +$62K +33.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $1.13M $258K -$723K -73.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.85M $268K -$813K -75.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.66M $417K -$650K -60.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.31M $184K -$1.17M -86.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $4.48M $981K -$110K -10.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $4.59M $1.08M -$1.91M -63.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $6.5M $1.07M -$2.4M -69.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-16
Q4 2021 $8.9M $1.35M -$11.3M -89.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-27
Q3 2021 $20.2M $1.09M -$546K -33.4% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-06
Q2 2021 $20.8M $2.99M -$3.04M -50.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $23.8M $3.46M +$63K +1.85% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $23.8M $12.7M +$10.9M +590% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 $12.9M $1.64M -$626K -27.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.5M $6.03M +$3.52M +140% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $10M $3.4M +$1.44M +73.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $8.58M $1.84M +$83K +4.73% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $8.5M $2.26M -$2.47M -52.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $11M $2.52M -$8.15M -76.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $19.1M $1.96M +$1.27M +185% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $17.8M $1.76M +$1.54M +721% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $16.3M $4.74M +$4.52M +2092% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $11.8M $10.7M +$10.5M +4930% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.33M $688K +$469K +214% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $861K $214K -$247K -53.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $1.11M $216K +$133K +160% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $975K $212K +$39.3K +22.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $935K $219K -$496K -69.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $1.43M $461K +$118K +34.4% Oct 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
Q3 2016 $1.31M $83K -$283K -77.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.6M $173K -$204K -54.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $1.8M $715K +$416K +139% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $1.38M $343K +$86.3K +33.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $1.3M $366K +$228K +165% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.07M $377K +$257K +213% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $814K $299K +$201K +205% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $613K $257K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 $138K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $120K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $98.1K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.